In-process quality control of biotherapeutics, such as monoclonal antibodies, requires computationally efficient process models that use readily measured process variables to compute product quality. Existing kinetic cell culture models can effectively describe the underlying mechanisms but require considerable development and parameterisation effort. Stoichiometric models, on the other hand, provide a generic, parameter-free means for describing metabolic behaviour but do not extend to product quality prediction. We have overcome this limitation by integrating a stoichiometric model of Chinese hamster ovary (CHO) cell metabolism with an artificial neural network that uses the fluxes of nucleotide sugar donor synthesis to compute the profil...
Exerting control over the glycan moieties of antibody therapeutics is highly desirable from a produc...
Protein glycosylation is one of the most important product quality attributes and impacts efficacy, ...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
Chinese hamster ovary (CHO) cells are the workhorse of the multibillion-dollar biopharmaceuticals in...
The production of recombinant therapeutic monoclonal antibodies (mAbs) using cultured mammalian cell...
The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated recombin...
<div><p>The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated ...
Ogunnaike, Babatunde A.Robinson, Anne S.Monoclonal antibodies (mAbs) are a class of commercially val...
N-linked glycosylation is known to be a crucial factor for the therapeutic efficacy and safety of mo...
Kinetic models offer incomparable insight on cellular mechanisms controlling protein glycosylation. ...
Monoclonal antibody therapeutics continue to grow in both number and market share with recent foreca...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
All commercially-available therapeutic monoclonal antibodies (mAbs) contain a consensus N-linked gly...
The terminal sugar molecules of the N-linked glycan attached to the fragment crystalizable (Fc) regi...
To function as intended in vivo, a majority of biopharmaceuticals require specific glycan distributi...
Exerting control over the glycan moieties of antibody therapeutics is highly desirable from a produc...
Protein glycosylation is one of the most important product quality attributes and impacts efficacy, ...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
Chinese hamster ovary (CHO) cells are the workhorse of the multibillion-dollar biopharmaceuticals in...
The production of recombinant therapeutic monoclonal antibodies (mAbs) using cultured mammalian cell...
The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated recombin...
<div><p>The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated ...
Ogunnaike, Babatunde A.Robinson, Anne S.Monoclonal antibodies (mAbs) are a class of commercially val...
N-linked glycosylation is known to be a crucial factor for the therapeutic efficacy and safety of mo...
Kinetic models offer incomparable insight on cellular mechanisms controlling protein glycosylation. ...
Monoclonal antibody therapeutics continue to grow in both number and market share with recent foreca...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...
All commercially-available therapeutic monoclonal antibodies (mAbs) contain a consensus N-linked gly...
The terminal sugar molecules of the N-linked glycan attached to the fragment crystalizable (Fc) regi...
To function as intended in vivo, a majority of biopharmaceuticals require specific glycan distributi...
Exerting control over the glycan moieties of antibody therapeutics is highly desirable from a produc...
Protein glycosylation is one of the most important product quality attributes and impacts efficacy, ...
Glycoproteins represent the largest group of the growing number of biologically-derived medicines. T...